ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Corza Medical Launches Next-Generation Microsurgical Sutures

Onatec Ophthalmic Sutures

WESTWOOD, Mass., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, announced the launch of its innovative new line of Onatec ophthalmic microsurgical sutures, unveiled at the American Academy of Ophthalmology (AAO) conference in Chicago October 18-21.

“Onatec represents Corza Medical's commitment to innovation and growth in the ophthalmic surgery market,” said Tom Testa, CEO of Corza Medical. “With Onatec, we are positioned to deliver tailored, high-quality solutions that address the evolving needs of a global market. Our dedication to meeting unmet clinical needs of our customers enhances our value proposition and strengthens our position as a trusted partner in the future of eye care.”

Corza Medical crafts Onatec needles from highly tempered stainless steel, ensuring high bending resistance and durability. The innovative and exceptional automated manufacturing process allows for precise needle geometries and accurate grinds, enabling stitching of the finest types of tissue in the smallest spaces. The high-quality surface finishing of Onatec needles ensures optimal penetration, resulting in less trauma to the tissue and enhanced patient comfort.

Jack Simmons, SVP & GM of Ophthalmology at Corza Medical, stated, “Onatec signifies a momentous advancement in Corza Medical’s ability to better meet our ophthalmic partners' needs. This newly launched ophthalmic suture portfolio not only enhances Corza’s product offerings but also provides the unique opportunity to support every aspect of the surgical treatment journey, from initial incision to closure.”

Founded over 30 years ago, Corza Medical’s Ophthalmology business is dedicated to advancing eye care worldwide. Its customer-focused approach drives the development of innovative ophthalmic surgical solutions that empower healthcare professionals and enhance patient outcomes through a comprehensive and holistic portfolio. The recent launch of Onatec at the AAO conference reinforces the company’s commitment to excellence and solidifies its position as a trusted leader in the medical technology industry. Additionally, to better support customers, Corza Medical Ophthalmology recently announced the launch of its newly enhanced website, corzaeye.com, which offers valuable resources and information tailored to the needs of eye care professionals.

About Corza Medical
Corza Medical is a leading global medical technology company that specializes in innovative surgical solutions and technologies. With a global team of approximately 3,000 employees supporting clinicians, distributor partners and medical device companies worldwide, Corza provides healthcare professionals with a platform of surgical technologies featuring many industry-leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look™ surgical sutures, Katena® reusable and Blink™ single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint® microsurgical knives and the TachoSil® fibrin sealant patch. For more information, please visit www.corza.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7fc4fa43-faf0-403a-b9f6-2839eb2b552a


Media Contact
Luci Curi
Director, Communications & PR
media@corza.com

Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.30
+0.00 (0.00%)
AAPL  259.48
+0.00 (0.00%)
AMD  236.73
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  338.53
+0.00 (0.00%)
META  716.50
+0.00 (0.00%)
MSFT  430.29
+0.00 (0.00%)
NVDA  191.13
+0.00 (0.00%)
ORCL  164.58
+0.00 (0.00%)
TSLA  430.41
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.